Third Quarter 2014 Financial Results
Genmab will report its Third Quarter 2014 financial results after market close on November 5. An investor conference call to discuss the results will be held at 6PM CET/12PM EST on November 5. To join the call by phone, dial one of the following numbers and ask for the Genmab conference call: +45 3272 8018 in Denmark, +44 1452 555 131 in the UK or +1 866 682 8490 in the US. Click here to listen to the webcast.
Genmab's CEO shares his perspective on how the company's work to develop innovative antibody therapeutics could change the lives of cancer patients in the future. Click here to watch the video.
Genmab is inviting researchers in academia and industry to experience the full power of the DuoBody® platform for bispecific antibody research and drug development. Explore the possibilities via our recently published Perspective in the journal mAbs and the renewed Open Innovation section on DuoBody.com.